Elekta´s opponent in U.S. patent dispute denied reconsideration

ELEKTA'S OPPONENT IN U.S. PATENT DISPUTE DENIED RECONSIDERATIONOn Thursday October 30, 2003, the United States Court of Appeals for theFederal Circuit announced its decision to deny the petition from MedicalInstrumentation and Diagnostics Corporation (Midco), Elekta's opponentin the U.S. patent dispute, to reconsider its ruling issued on September22, 2003.As a result the ruling by the court, which among other findingsdetermined that none of Elekta's products infringed the Midco patentsand in which Elekta was freed from all liability, remains valid.Midco may file a petition for review (certiorari) with the United StatesSupreme Court. Grant of this remedy is very unusual.The full opinion of the court from September 22 is available atwww.fedcir.gov/dailylog.html, docket no. 03-1032. ***********For further information, please contact:Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ),Phone: +46 8 587 254 00, e-mail: peter.ejemyr@elekta.comElekta is a world-leading supplier of advanced and innovative radiationoncology and neurosurgery solutions and services for precise treatmentof cancer and brain disorders. Elekta's solutions are clinicallyeffective, cost efficient and gentle to the patient.For additional information about Elekta, please visit www.elekta.com------------------------------------------------------------This information was brought to you by Waymaker http://www.waymaker.netThe following files are available for download:http://www.waymaker.net/bitonline/2003/10/31/20031031BIT00040/wkr0001.doc http://www.waymaker.net/bitonline/2003/10/31/20031031BIT00040/wkr0002.pdf